John Twomey
🏛️ Revolving DoorFormer Government Position:
Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
🤖
AI Overview
John Twomey has appeared in 458 federal lobbying filings at Tiber Creek Group, representing 44 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 29 policy areas.
458
Total Filings
1
Firms
44
Clients
29
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2021 | 53 | 13 |
| 2022 | 81 | 13 |
| 2023 | 100 | 17 |
| 2024 | 90 | 17 |
| 2025 | 134 | 26 |
Firms
Tiber Creek Group458 filings
Top Clients
Cigna Corporation and Subsidiaries48 filings
Bloom Energy32 filings
Nusano, INC.28 filings
Nvidia Corporation21 filings
Academy of Managed Care Pharmacy18 filings
Everytown for Gun Safety Action Fund18 filings
Energy Storage Itc Coalition17 filings
Sierra Club16 filings
Accountable for Health15 filings
Alnylam Pharmaceuticals, INC.13 filings
Astrazeneca13 filings
Quidnet Energy, INC.12 filings
Agilon Health, INC.12 filings
Retractable Technologies, INC.11 filings
Solventum Corporation10 filings
Smiths Group PLC9 filings
Marklogic8 filings
Prevent Opioid Abuse8 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.